Cardurion Pharmaceuticals, Inc.

This completed Phase 2 trial tested whether the experimental drug tovinontrine could help control heart failure in patients whose hearts pump normally but still struggle. The study involved 303 adults with chronic heart failure symptoms who received either the drug or a placebo f…

This study tested whether a new drug called tovinontrine could help control chronic heart failure. It involved 557 adults with a weakened heart pump who were already on standard treatments. Researchers compared the drug to a placebo over 12 weeks, looking at changes in key blood …